In addition, FLLL31 and FLLL32, 2 novel small-molecule STAT3 inhibitors, derived from curcumin, inhibited multiple oncogenic processes, induced apoptosis in PCC lines, and reduced tumor growth and vascularity PDA mouse xenografts [44]. The gene discussed is STAT3; the disease is Patent ductus arteriosus.